Investing.com - AstraZeneca (NASDAQ:AZN) reported on Friday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
AstraZeneca announced earnings per share of $1.89 on revenue of $11.39B. Analysts polled by Investing.com anticipated EPS of $1.65 on revenue of $10.74B.
AstraZeneca shares are down 26% from the beginning of the year, still down 3.55% from its 52 week high of $11,000.00 set on April 8. They are under-performing the STOXX 600 which is down 7.4% from the start of the year.
AstraZeneca shares gained 0.45% in intra-day trade following the report.
AstraZeneca follows other major Healthcare sector earnings this month
AstraZeneca's report follows an earnings beat by GlaxoSmithKline on Wednesday, who reported EPS of $0.328 on revenue of $9.78B, compared to forecasts EPS of $0.2902 on revenue of $8.95B.
Oxford BioMedica had missed expectations on April 20 with first quarter EPS of $0.01 on revenue of $61.55M, compared to forecast for EPS of $7.80 on revenue of $77.28M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar